6Z6W
 
 | | Poliovirus type 3 (strain Saukett) stabilised virus-like particle (PV3 SC8) from a mammalian expression system. | | Descriptor: | Capsid proteins, VP0, VP1, ... | | Authors: | Bahar, M.W, Porta, C, Fry, E.E, Stuart, D.I. | | Deposit date: | 2020-05-29 | | Release date: | 2020-12-30 | | Last modified: | 2024-07-10 | | Method: | ELECTRON MICROSCOPY (3 Å) | | Cite: | Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines. NPJ Vaccines, 6, 2021
|
|
2VGA
 
 | | The structure of Vaccinia virus A41 | | Descriptor: | PROTEIN A41 | | Authors: | Bahar, M.W, Kenyon, J.C, Putz, M.M, Abrescia, N.G.A, Pease, J.E, Wise, E.L, Stuart, D.I, Smith, G.L, Grimes, J.M. | | Deposit date: | 2007-11-09 | | Release date: | 2008-02-26 | | Last modified: | 2024-10-16 | | Method: | X-RAY DIFFRACTION (1.9 Å) | | Cite: | Structure and Function of A41, a Vaccinia Virus Chemokine Binding Protein. Plos Pathog., 4, 2008
|
|
5O5B
 
 | | Poliovirus type 3 (strain Saukett) stabilized virus-like particle | | Descriptor: | Capsid proteins, VP1, VP2, ... | | Authors: | Bahar, M.W, Kotecha, A, Fry, E.E, Stuart, D.I. | | Deposit date: | 2017-06-01 | | Release date: | 2017-07-12 | | Last modified: | 2024-07-10 | | Method: | ELECTRON MICROSCOPY (3.6 Å) | | Cite: | Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. Nat Commun, 8, 2017
|
|
5O5P
 
 | | Poliovirus type 3 (strain Saukett) stabilized virus-like particle in complex with the pocket factor compound GPP3 | | Descriptor: | 1-[5-[4-(ethoxyiminomethyl)phenoxy]-3-methyl-pentyl]-3-pyridin-4-yl-imidazol-2-one, Capsid proteins, VP4, ... | | Authors: | Bahar, M.W, Kotecha, A, Fry, E.E, Stuart, D.I. | | Deposit date: | 2017-06-02 | | Release date: | 2017-07-12 | | Last modified: | 2024-07-10 | | Method: | ELECTRON MICROSCOPY (4.1 Å) | | Cite: | Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. Nat Commun, 8, 2017
|
|
9H94
 
 | | Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC5a) from a yeast expression system. | | Descriptor: | Capsid protein VP0, Capsid protein VP1, Capsid protein VP3, ... | | Authors: | Bahar, M.W, Sherry, L, Stonehouse, N.J, Rowlands, D.J, Fry, E.E, Stuart, D.I. | | Deposit date: | 2024-10-29 | | Release date: | 2025-04-02 | | Last modified: | 2025-04-09 | | Method: | ELECTRON MICROSCOPY (2.1 Å) | | Cite: | Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation. Npj Vaccines, 10, 2025
|
|
9H93
 
 | | Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC6b) from a yeast expression system. | | Descriptor: | Capsid protein VP1, Capsid protein VP3, Capsid protein, ... | | Authors: | Bahar, M.W, Sherry, L, Stonehouse, N.J, Rowlands, D.J, Fry, E.E, Stuart, D.I. | | Deposit date: | 2024-10-29 | | Release date: | 2025-04-02 | | Last modified: | 2025-04-09 | | Method: | ELECTRON MICROSCOPY (2.4 Å) | | Cite: | Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation. Npj Vaccines, 10, 2025
|
|
8ANW
 
 | | Poliovirus type 3 (strain Saukett) stabilised virus-like particle (PV3 SC8). | | Descriptor: | Capsid protein, VP0, VP1, ... | | Authors: | Bahar, M.W, Fry, E.E, Stuart, D.I. | | Deposit date: | 2022-08-06 | | Release date: | 2022-10-12 | | Last modified: | 2024-03-27 | | Method: | ELECTRON MICROSCOPY (2.7 Å) | | Cite: | Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris . Viruses, 14, 2022
|
|
8AYY
 
 | | Poliovirus type 3 (strain Saukett) stabilised virus-like particle (PV3 SC8) in complex with GSH and Pleconaril | | Descriptor: | 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE, Capsid protein, VP0, ... | | Authors: | Bahar, M.W, Fry, E.E, Stuart, D.I. | | Deposit date: | 2022-09-04 | | Release date: | 2022-12-07 | | Last modified: | 2024-07-24 | | Method: | ELECTRON MICROSCOPY (2.6 Å) | | Cite: | A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation. Commun Biol, 5, 2022
|
|
8AYX
 
 | | Poliovirus type 3 (strain Saukett) stabilised virus-like particle (PV3 SC8) in complex with GSH and GPP3 | | Descriptor: | 1-[(3S)-5-[4-[(E)-ETHOXYIMINOMETHYL]PHENOXY]-3-METHYL-PENTYL]-3-PYRIDIN-4-YL-IMIDAZOLIDIN-2-ONE, Capsid protein, VP0, ... | | Authors: | Bahar, M.W, Fry, E.E, Stuart, D.I. | | Deposit date: | 2022-09-04 | | Release date: | 2022-12-07 | | Last modified: | 2024-07-24 | | Method: | ELECTRON MICROSCOPY (2.5 Å) | | Cite: | A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation. Commun Biol, 5, 2022
|
|
8AYZ
 
 | | Poliovirus type 2 (strain MEF-1) virus-like particle in complex with capsid binder compound 17 | | Descriptor: | 4-[[4-[1,3-bis(oxidanylidene)isoindol-2-yl]phenyl]sulfonylamino]benzoic acid, Capsid protein, VP0, ... | | Authors: | Bahar, M.W, Fry, E.E, Stuart, D.I. | | Deposit date: | 2022-09-04 | | Release date: | 2022-12-07 | | Last modified: | 2024-07-24 | | Method: | ELECTRON MICROSCOPY (1.88 Å) | | Cite: | A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation. Commun Biol, 5, 2022
|
|
3ZED
 
 | | X-ray structure of the birnavirus VP1-VP3 complex | | Descriptor: | CAPSID PROTEIN VP3, GLYCEROL, POTASSIUM ION, ... | | Authors: | Bahar, M.W, Sarin, L.P, Graham, S.C, Pang, J, Bamford, D.H, Stuart, D.I, Grimes, J.M. | | Deposit date: | 2012-12-04 | | Release date: | 2013-01-16 | | Last modified: | 2023-12-20 | | Method: | X-RAY DIFFRACTION (2.2 Å) | | Cite: | Structure of a Vp1-Vp3 Complex Suggests How Birnaviruses Package the Vp1 Polymerase. J.Virol., 87, 2013
|
|
9F59
 
 | | Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC6b) from a mammalian expression system. | | Descriptor: | Capsid protein VP0, Capsid protein VP1, Capsid protein VP3, ... | | Authors: | Bahar, M.W, Porta, C, Fry, E.E, Stuart, D.I. | | Deposit date: | 2024-04-28 | | Release date: | 2025-01-29 | | Method: | ELECTRON MICROSCOPY (2.3 Å) | | Cite: | Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines. Nat Commun, 16, 2025
|
|
9F5P
 
 | | Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC6b) from an insect cell expression system. | | Descriptor: | Capsid protein VP0, Capsid protein VP1, Capsid protein VP3, ... | | Authors: | Bahar, M.W, Porta, C, Fry, E.E, Stuart, D.I. | | Deposit date: | 2024-04-29 | | Release date: | 2025-01-29 | | Method: | ELECTRON MICROSCOPY (2.6 Å) | | Cite: | Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines. Nat Commun, 16, 2025
|
|
9EZ0
 
 | | Poliovirus type 1 (strain Mahoney) expanded conformation stabilised virus-like particle (PV1 SC6b) from a yeast expression system. | | Descriptor: | Capsid protein VP0, Capsid protein VP1, Capsid protein VP3 | | Authors: | Bahar, M.W, Sherry, L, Stonehouse, N.J, Rowlands, D.J, Fry, E.E, Stuart, D.I. | | Deposit date: | 2024-04-10 | | Release date: | 2025-01-29 | | Method: | ELECTRON MICROSCOPY (3.3 Å) | | Cite: | Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines. Nat Commun, 16, 2025
|
|
9EYY
 
 | | Poliovirus type 1 (strain Mahoney) native conformation stabilised virus-like particle (PV1 SC6b) from a yeast expression system. | | Descriptor: | Capsid protein VP0, Capsid protein VP1, Capsid protein VP3, ... | | Authors: | Bahar, M.W, Sherry, L, Stonehouse, N.J, Rowlands, D.J, Fry, E.E, Stuart, D.I. | | Deposit date: | 2024-04-09 | | Release date: | 2025-01-29 | | Method: | ELECTRON MICROSCOPY (3.3 Å) | | Cite: | Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines. Nat Commun, 16, 2025
|
|
9F0K
 
 | | Poliovirus type 1 (strain Mahoney) expanded conformation stabilised virus-like particle (PV1 SC6b) from a mammalian expression system | | Descriptor: | Capsid protein VP0, Capsid protein VP1, Capsid protein VP3 | | Authors: | Bahar, M.W, Porta, C, Fry, E.E, Stuart, D.I. | | Deposit date: | 2024-04-16 | | Release date: | 2025-01-29 | | Method: | ELECTRON MICROSCOPY (3 Å) | | Cite: | Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines. Nat Commun, 16, 2025
|
|
9F3Q
 
 | | Poliovirus type 1 (strain Mahoney) stabilised virus-like particle (PV1 SC6b) in complex with GPP3 and GSH. | | Descriptor: | 1-[(3S)-5-[4-[(E)-ETHOXYIMINOMETHYL]PHENOXY]-3-METHYL-PENTYL]-3-PYRIDIN-4-YL-IMIDAZOLIDIN-2-ONE, Capsid protein VP0, Capsid protein VP1, ... | | Authors: | Bahar, M.W, Nasta, V, Sherry, L, Stonehouse, N.J, Rowlands, D.J, Fry, E.E, Stuart, D.I. | | Deposit date: | 2024-04-25 | | Release date: | 2025-01-29 | | Method: | ELECTRON MICROSCOPY (2.75 Å) | | Cite: | Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines. Nat Commun, 16, 2025
|
|
2YGB
 
 | |
2YGC
 
 | |
1W9Z
 
 | | Structure of Bannavirus VP9 | | Descriptor: | VP9 | | Authors: | Jaafar, F.M, Attoui, H, Bahar, M.W, Siebold, C, Sutton, G, Mertens, P.P.C, Micco, P, Stuart, D.I, Grimes, J.M, Lamballerie, X. | | Deposit date: | 2004-10-21 | | Release date: | 2005-04-01 | | Last modified: | 2024-05-08 | | Method: | X-RAY DIFFRACTION (2.56 Å) | | Cite: | The Structure and Function of the Outer Coat Protein Vp9 of Banna Virus Structure, 13, 2005
|
|
4BBB
 
 | | THE STRUCTURE OF VACCINIA VIRUS N1 Q61Y MUTANT | | Descriptor: | N1L | | Authors: | Maluquer de Motes, C, Cooray, S, McGourty, K, Ren, H, Bahar, M.W, Stuart, D.I, Grimes, J.M, Graham, S.C, Smith, G.L. | | Deposit date: | 2012-09-21 | | Release date: | 2012-10-03 | | Last modified: | 2023-12-20 | | Method: | X-RAY DIFFRACTION (3.09 Å) | | Cite: | Inhibition of Apoptosis and NF-kappaB Activation by Vaccinia Protein N1 Occur Via Distinct Binding Surfaces and Make Different Contributions to Virulence. Plos Pathog., 7, 2011
|
|
4BBD
 
 | | THE STRUCTURE OF VACCINIA VIRUS N1 R58Y MUTANT | | Descriptor: | N1L | | Authors: | Maluquer de Motes, C, Cooray, S, McGourty, K, Ren, H, Bahar, M.W, Stuart, D.I, Grimes, J.M, Graham, S.C, Smith, G.L. | | Deposit date: | 2012-09-21 | | Release date: | 2012-10-03 | | Last modified: | 2023-12-20 | | Method: | X-RAY DIFFRACTION (3 Å) | | Cite: | Inhibition of Apoptosis and NF-kappaB Activation by Vaccinia Protein N1 Occur Via Distinct Binding Surfaces and Make Different Contributions to Virulence. Plos Pathog., 7, 2011
|
|
4BBC
 
 | | THE STRUCTURE OF VACCINIA VIRUS N1 R71Y MUTANT | | Descriptor: | N1L | | Authors: | Maluquer de Motes, C, Cooray, S, McGourty, K, Ren, H, Bahar, M.W, Stuart, D.I, Grimes, J.M, Graham, S.C, Smith, G.L. | | Deposit date: | 2012-09-21 | | Release date: | 2012-10-03 | | Last modified: | 2023-12-20 | | Method: | X-RAY DIFFRACTION (3.1 Å) | | Cite: | Inhibition of Apoptosis and NF-kappaB Activation by Vaccinia Protein N1 Occur Via Distinct Binding Surfaces and Make Different Contributions to Virulence. Plos Pathog., 7, 2011
|
|
2VVY
 
 | | Structure of Vaccinia virus protein B14 | | Descriptor: | PROTEIN B15 | | Authors: | Graham, S.C, Bahar, M.W, Cooray, S, Chen, R.A.-J, Whalen, D.M, Abrescia, N.G.A, Alderton, D, Owens, R.J, Stuart, D.I, Smith, G.L, Grimes, J.M. | | Deposit date: | 2008-06-12 | | Release date: | 2008-08-26 | | Last modified: | 2024-10-16 | | Method: | X-RAY DIFFRACTION (2.693 Å) | | Cite: | Vaccinia Virus Proteins A52 and B14 Share a Bcl-2-Like Fold But Have Evolved to Inhibit NF-kappaB Rather Than Apoptosis Plos Pathog., 4, 2008
|
|
2VVX
 
 | | Structure of Vaccinia virus protein A52 | | Descriptor: | PROTEIN A52 | | Authors: | Graham, S.C, Bahar, M.W, Cooray, S, Chen, R.A.-J, Whalen, D.M, Abrescia, N.G.A, Alderton, D, Owens, R.J, Stuart, D.I, Smith, G.L, Grimes, J.M. | | Deposit date: | 2008-06-12 | | Release date: | 2008-08-26 | | Last modified: | 2023-12-13 | | Method: | X-RAY DIFFRACTION (2.746 Å) | | Cite: | Vaccinia Virus Proteins A52 and B14 Share a Bcl-2-Like Fold But Have Evolved to Inhibit NF-kappaB Rather Than Apoptosis Plos Pathog., 4, 2008
|
|